Your browser doesn't support javascript.
loading
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lim, Sung-Nam; Joo, Young-Don; Lee, Kyoo-Hyung; Kim, Dae-Young; Lee, Je-Hwan; Lee, Jung-Hee; Chi, Hyun-Sook; Yun, Sung-Cheol; Lee, Won Sik; Lee, Sang Min; Park, Seonyang; Kim, Inho; Sohn, Sang Kyun; Moon, Joon Ho; Ryoo, Hun-Mo; Bae, Sung Hwa; Hyun, Myung Soo; Kim, Min Kyoung; Kim, Hyeoung Joon; Yang, Deok-Hwan; Eom, Hyeon-Seok; Lee, Gyeong-Won; Jung, Chul Won; Won, Jong-Ho; Kim, Hawk; Lee, Jae-Hoon; Shin, Ho-Jin; Jang, Dae-Young.
Afiliación
  • Lim SN; Hematology-Oncology, Department of Internal Medicine, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea.
  • Joo YD; Hematology-Oncology, Department of Internal Medicine, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea.
  • Lee KH; Hematology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Kim DY; Hematology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Lee JH; Hematology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Lee JH; Hematology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Chi HS; Department of Laboratory Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Yun SC; Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Lee WS; Hematology-Oncology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospitals, Busan, Korea.
  • Lee SM; Hematology-Oncology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospitals, Busan, Korea.
  • Park S; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
  • Kim I; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
  • Sohn SK; Hematology, Department of Internal Medicine, Kyungpook National University School of Medicine, Kyungpook National University Hospital, Daegu, Korea.
  • Moon JH; Hematology, Department of Internal Medicine, Kyungpook National University School of Medicine, Kyungpook National University Hospital, Daegu, Korea.
  • Ryoo HM; Hematology-Oncology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, Catholic University Medical Center, Daegu, Korea.
  • Bae SH; Hematology-Oncology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, Catholic University Medical Center, Daegu, Korea.
  • Hyun MS; Hematology-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Yeungnam University Medical Center, Daegu, Korea.
  • Kim MK; Hematology-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Yeungnam University Medical Center, Daegu, Korea.
  • Kim HJ; Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Yang DH; Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Eom HS; Hematology-Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center, Ilsan, Korea.
  • Lee GW; Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Korea.
  • Jung CW; Hematology-Oncology, Department of Internal Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
  • Won JH; Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Korea.
  • Kim H; Division of Hematology and Cellular Therapy, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.
  • Lee JH; Hematology-Oncology, Department of Internal Medicine, Gachon University of Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • Shin HJ; Hematology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea.
  • Jang DY; Hematology-Oncology, Department of Internal Medicine, Hallym University College of Medicine, Hallym Medical Center, Anyang, Korea.
Am J Hematol ; 90(11): 1013-20, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26228525
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras / Quimioterapia de Inducción / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras / Quimioterapia de Inducción / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2015 Tipo del documento: Article